CN1212889A - Traditional Chinese medicine component for improving immunocompetence and having effect on multiple epidemic diseases - Google Patents
Traditional Chinese medicine component for improving immunocompetence and having effect on multiple epidemic diseases Download PDFInfo
- Publication number
- CN1212889A CN1212889A CN 97116961 CN97116961A CN1212889A CN 1212889 A CN1212889 A CN 1212889A CN 97116961 CN97116961 CN 97116961 CN 97116961 A CN97116961 A CN 97116961A CN 1212889 A CN1212889 A CN 1212889A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- effect
- immunocompetence
- medicine component
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A Chinese medicine component for increasing immunity and high effect to many diseases such as diabetes is prepared from edible fungus, astragulus root and Ramulus euonymia, and serves to reduce blood sugar and blood fat, improving microcirculation of blood, and prevent complication. It also has better curative effect to cancer.
Description
The present invention relates to medical manufacturing field, more specifically say so about the Chinese medicine preparation of treatment diabetes and raising immunocompetence.
Diabetes are common frdquently encountered diseases of serious harm human health, and diabetics surpasses 100,000,000 people in the world at present, and also there is the trend that increases year by year in China nearly 20,000,000.
Diabetes do not heal all the life, its complication extensively and seriously, because insulin lacks relatively or definitely in the blood, cause sugar, fat, protein metabolism disorder, cause hyperglycemia, hyperlipidemia and blood viscosity to raise, extensively microangiopathies of the whole body appears in middle and advanced stage, and wherein 70-80% patient dies from the cardiovascular diseases.
Both at home and abroad to this sick Drug therapy, have following several problem: 1, biguanide drug: the curative effect toxic and side effects is big at present, for a long time with producing hyperlactacidemia; 2, sulfaurea drugs: for a long time with damaging liver, kidney and hemocyte, with the sulfonamides cross allergy, the later stage produces secondary failure; 3, insulin: with producing antibody, biological activity reduces for a long time, and dosage increases, and produces hyperinsulinemia, impels microangiopathies to take place and development.
The object of the present invention is to provide a kind of blood sugar lowering that has, blood fat reducing improves the blood clotting state, and the mediation microcirculation increases immunity of organism, reduces the diabetes preparation of diabetes-alleviating complication.
Solution of the present invention is based on motherland's medical science to diabetes and complication pathogeny thereof, understanding and Therapeutic Principle, again in conjunction with people in recent years to the understanding and the progress of edible fungi, utilize their superior characteristics of curing the disease separately, based on edible fungi, press the theory of Chinese medical science prescription with the modern science cognitive analysis, design, make, skim the cream off milk, promote endogenous secretion of insulin, reduce exogenous insulin periphery drag, increase biological activity, promote the metabolism of sugar, reduce fat protein and decompose, make blood pressure and blood lipoid reduce microcirculation improvement, reduce diabetes-alleviating patient cardiovascular pathological changes and develop.People Fei Te epidemic disease immunocompetence is improved.The ability of balance T cell and β cell and activity are owing to use modern science design philosophy to make the present invention simple, because raw material, component are few, therefore be convenient to grasp the mechanism of really curing the disease of various raw materials more, avoided too much, caused medication inaccurate, the problem that mechanism is obstructed because of the component kind.
The present invention is main by following three kinds of raw materials: 1. edible fungi: be mainly Grifola frondosa and Pleurotus ostreatus all can; 2. the Radix Astragali: mainly adopt Radix Astragali; 3. Ramulus Euonymi.
Edible fungi is the nourishing food of a kind of delicious food, body-building, not only edible but also can be used for producing antibiotic and various medicine.A large amount of compositions to the human body beneficial are arranged, as polysaccharide, purine, steroidal etc. in edible fungi.Can promote and regulate and control the metabolism of human body, improve the immunocompetence of body, play the effect that prevents and treat multiple disease, also have the concrete effect of the following aspects:
1, stimulate body to produce antibody, improve immunocompetence, prevent or eliminate alien bacteria, virus and paracytic invasion and attack and generation, the oxygen delivery capacity that can improve in the body blood reduces the effective consumption of body to oxygen, improves the utilization rate of oxygen.
2, edible fungi also can produce antibiotic, as isolating pleurin from pleurotus, has broad spectrum activity, and multiple pathogenic bacteria is all had higher antibacterial activity.Virus also there is certain inhibitory action.
3, the antitumor action of edible fungi, through deeply screening, finding has more than 150 kind of bacterium to contain polysaccharide, and it can stimulate body, and the generation immune function plays and suppresses the growth of tumour cell effect, and antitumor action is quite remarkable.
The Radix Astragali is the root of the pulse family herbaceos perennial Radix Astragali, contain saccharide, choline folic acid, β-sitosterol, also contain 2 ', 4 dihydroxy ,-5,6-dimethoxy and flavone, to the multiple effect that inhibition is arranged to pathogenic bacteria, can also strengthen normal contraction, the heart of depletion is had strong effect, can freely contain blood circulation blood glucose is descended, sedation, the conversion of all right activated lymphocyte delays the decline of total complement amount, the non-characteristic immunity of energy enhancing body.
Ramulus Euonymi is machaka, contains freidelin, Quercetin and oxalacetyl sodium in its branch and leaf, and stronger hypoglycemic activity is arranged, and can make the propagation of islet cells during use, and abnormal metabolic process is adjusted in pancreas β hyperplasia, strengthens secretion of insulin.
More than three kinds of raw materials quite good characteristics are all arranged on pharmacodynamics, but because its real active ingredient is considerably less in raw material itself, therefore be not enough in order to treat and to keep healthy, for example modern science is thought the bacterium of picking up the ears in the edible fungi, the very effective antibacterial anti-viral effect of wide spectrum is arranged, but since in edible fungi in the middle of the sporophore content considerably less, the into relatively large commercialization of therefore failing.
Another object of the present invention utilizes existing means that three kinds of raw materials are carried out extracting with effective ingredient exactly, and is concentrated relatively, or less preparation, is convenient to user and uses, and strengthened the ratio of active ingredient simultaneously.And when processed, making chemical analysis in the raw material, synthetic again new chemical compound makes drug effect outstanding more and obvious.
Component content of the present invention (weight %): major ingredient Grifola frondosa, Pleurotus ostreatus 40-95%, be preferably 60%, Radix Astragali 3-20% is preferably 20%, Ramulus Euonymi 3-20%.Be preferably 20%.
Grifola frondosa, Pleurotus ostreatus all can cooperate with the Radix Astragali, Ramulus Euonymi separately in component of the present invention.
Another important feature of the present invention is to contain abundant choline material, and flavone compound, and flavone compound can increase the islets of langerhans blood perfusion, helps the synthetic and secretion of insulin.
Embodiment:
Get 60 kilograms of commercially available dried massee fruiting bodies, 20 kilograms of the Radixs Astragali, 20 kilograms of Ramulus Euonymis, the raw materials used intensive drying thing that is necessary for, fresh, nothing is gone mouldy, free from extraneous odour, and impurity is rejected clean, three kinds of raw materials are mixed, pulverize with pulverizer, with the sub-sieving for standby of 60 mesh sieves.
With the material powder after pulverizing, put into to boil and carry jar, added entry by 1: 8, be heated to 90-95 ℃ and carry out homogenizing, stop after 15 minutes heating, natural cooling is put into the centrifuge separation and Extraction during to 45-50 ℃.With the residue after the lixiviate first time, the water that adds 2 times is in 85-90 ℃ of down heating 20 minutes, puts centrifugally in people's centrifuge to carry out extraction second time.
With go in the residue after the lixiviate second time 2 times water in 80 ℃ down heating put into after 20 minutes that centrifuge is centrifugal to be extracted for the third time.
Above-mentioned 3 extracting solution are merged, and at this moment active ingredient is lower in extract, and one has only about 0.5%.When extracting solution is concentrated into content 20%, under 50-60 ℃, carry out spray drying.
Rapidly spray drying gained powder is incapsulated.
The experiment to diabetic rabbit blood glucose of the capsule made and matched group is seen the following form.Table 1 is mean blood glucose in three groups of each time of rabbit in the X ± SD administration 15 hours as a result.
This agent of table 2 is to the effect laboratory observation research table II of artificial diabetes
Time (hour) | ??0.5 | ????1 | ???2 | ????3 | ????4 | ????5 | ????6 | ????7 | ????8 | ????9 | ???10 | ???11 | ???12 | ???13 | ???14 | ????15 |
The healthy rabbits matched group | 92±10 | 90±8 | 92±6 | 93±8 | 90±6 | 85±6 | 84±5 | 86±7 | 89±6 | 85±5 | 84±6 | 87±5 | 85±6 | 80±7 | 80±14 | 75±4* |
This agent | 200±10 | 200±6 | 190±5 | 194±8 | 196±4 | 201±5 | 200±7 | 191±4 | 196±5 | 185±4 | 195±4 | 192±6 | 190±4 | 190±6 | 190±5 | 166±6** |
The diabetes pill group | 192±10 | 194±5 | 196±7 | 194±6 | 196±4 | 200±5 | 196±6 | 196±4 | 208±6 | 210±4 | 200±6 | 196±6 | 196±4 | 180±5 | 180±5 | 180±2 |
1 day | 2 days | 3 days | 4 days | 5 days | 6 days | 7 days | 8 days | 9 days | 10 days | 15 days | 20 days | 25 days | 30 days | 35 days | 40 days | 45 days | 50 days | |
The healthy rabbits matched group | 77±55 | 82±5 | 80±6 | 81±5 | 83±6 | 80±5 | 81±7 | 80±6 | 80±7 | 80±8 | 81±7 | 82±4 | 83±3 | 80±6 | 82±6 | 83±6 | 80±6 | 81±3 |
Artificial diabetes blank group | 190±10 | 190±10 | 195±9 | 198±10 | 196±12 | 19.7±10 | 198±10 | 205±6 | 207±5 | 207±10 | 209±11 | 212±5 | 216±10 | 200±12 | 235±12 | 240±15 | 260±12 | 29D±12 |
This agent group | 1.70±6 | 170±2 | 195±5 | 163±5 | 150±8 | 162±7 | 110±5 | 108±5 | 106±6 | 103±7 | 100±6 | 98±7 | 98±7 | 85±5 | 76±5 | 88±4 | 80±4 | 82±56 |
The diabetes pill group | 183±24 | 180±6 | 1.79±5 | 181±6 | 179±6 | 179±7 | 180±6 | 179±5 | 181±5 | 184±5 | 1.70±6 | 170±5 | 170±6 | 165±6 | 169±5 | 160±4 | 160±5 | 140±4 |
By above two tables as can be known, this component is effective really to diabetes.
Claims (5)
1, a kind of immunocompetence that improves is to the effective Chinese medicine component of multiple eqpidemic disease, and it is characterized in that: it is made up of edible fungi Grifola frondosa, Pleurotus ostreatus and Chinese herb astragalus and Ramulus Euonymi.
2, according to claims 1 described a kind of immunocompetence that improves to the effective Chinese medicine component of multiple eqpidemic disease, it is characterized in that edible fungi Grifola frondosa, its component content of Pleurotus ostreatus are (weight %) 30-80%.
3, according to claims 1 described a kind of immunocompetence that improves to the effective Chinese medicine component of multiple eqpidemic disease, it is characterized in that: Radix Astragali component content is (weight %) 5-30%.
4, according to claims 1 described a kind of immunocompetence that improves to the effective Chinese medicine component of multiple eqpidemic disease, it is characterized in that: its component content of Ramulus Euonymi is 5-30%.
5, according to claims 2 described Grifola frondosa, ratio is any between the two for Pleurotus ostreatus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97116961 CN1212889A (en) | 1997-09-29 | 1997-09-29 | Traditional Chinese medicine component for improving immunocompetence and having effect on multiple epidemic diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97116961 CN1212889A (en) | 1997-09-29 | 1997-09-29 | Traditional Chinese medicine component for improving immunocompetence and having effect on multiple epidemic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1212889A true CN1212889A (en) | 1999-04-07 |
Family
ID=5174236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 97116961 Pending CN1212889A (en) | 1997-09-29 | 1997-09-29 | Traditional Chinese medicine component for improving immunocompetence and having effect on multiple epidemic diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1212889A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102055C (en) * | 2000-08-31 | 2003-02-26 | 史启茂 | Medicine for curing diabetes and its preparation method |
CN1321637C (en) * | 2002-09-29 | 2007-06-20 | 中国药科大学 | Chinese medicinal hypoglycemic agent and preparation thereof |
CN101259160B (en) * | 2008-04-18 | 2012-01-11 | 天津生机集团股份有限公司 | Compound preparations for treating birdsvirosis and preparation thereof |
CN106262805A (en) * | 2016-07-28 | 2017-01-04 | 福建万亿店中店电子商务有限责任公司 | A kind of for compositions preventing and treating hyperlipidemia and preparation method thereof |
CN106912949A (en) * | 2017-03-15 | 2017-07-04 | 福建农林大学 | A kind of grifola frondosus spirulina complex preparation health food and preparation method thereof |
-
1997
- 1997-09-29 CN CN 97116961 patent/CN1212889A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102055C (en) * | 2000-08-31 | 2003-02-26 | 史启茂 | Medicine for curing diabetes and its preparation method |
CN1321637C (en) * | 2002-09-29 | 2007-06-20 | 中国药科大学 | Chinese medicinal hypoglycemic agent and preparation thereof |
CN101259160B (en) * | 2008-04-18 | 2012-01-11 | 天津生机集团股份有限公司 | Compound preparations for treating birdsvirosis and preparation thereof |
CN106262805A (en) * | 2016-07-28 | 2017-01-04 | 福建万亿店中店电子商务有限责任公司 | A kind of for compositions preventing and treating hyperlipidemia and preparation method thereof |
CN106912949A (en) * | 2017-03-15 | 2017-07-04 | 福建农林大学 | A kind of grifola frondosus spirulina complex preparation health food and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103285231B (en) | Medicine composition for diabetes adjunctive therapy and preparation method thereof | |
CN102428832B (en) | Fungal pharmaceutical mycoplasm with blood sugar lowering efficacy and preparation method thereof | |
CN101152007B (en) | Health-care products composition and method for preparing the same | |
CN1762236A (en) | Health-caring product capable of increasing human immunity and its preparation method | |
CN111840363B (en) | Natto-assisted hypoglycemic health-care composition and preparation method and application thereof | |
CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
KR20100127420A (en) | Composition for improving bioavailability of saponin | |
CN107080250A (en) | A kind of composition of auxiliary hyperglycemic, beverage and preparation method thereof | |
Gulati et al. | Role of mushrooms in gestational diabetes mellitus | |
CN104337871A (en) | Blood sugar reducing capsule | |
CN1212889A (en) | Traditional Chinese medicine component for improving immunocompetence and having effect on multiple epidemic diseases | |
CN102090637A (en) | Collagen-containing compound nutritious powder | |
CN101336965B (en) | Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof | |
CN106581166A (en) | Anti-fatigue food, health product or pharmaceutical composition | |
CN1401365A (en) | Chinese health medicine | |
CN105145931A (en) | Hypoglycemic tea and making method thereof | |
CN113499366B (en) | Composition with function of reducing blood sugar and blood fat simultaneously and preparation method thereof | |
JP2011184349A (en) | Frequent urination-ameliorating composition, healthy food and blood flow-ameliorating composition | |
KR20090120202A (en) | Health food for the descent of hba1c | |
CN107893035A (en) | A kind of culture medium of Hericium erinaceus, sealwort bioconversion mycelium, the mycelial extract of sealwort bioconversion and application thereof | |
CN105233032A (en) | Traditional Chinese medicine for treating diabetes | |
CN111888431A (en) | Composition for treating diabetes and preparation method thereof | |
CN1084193C (en) | Medicine for lowering blood-sugar and nourishing the heart and method for preparing same | |
CN101637214A (en) | Chewing gum having effects of preventing and treating diabetes | |
CN101167887A (en) | Orally-administered matrimony vine single preparation traditional Chinese medicine for treating diabetes and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |